DRREDDY.NS : Summary for DR REDDYS LABS INR5 - Yahoo Finance

U.S. Markets closed

Dr. Reddy's Laboratories Limited (DRREDDY.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
2,631.20+1.55 (+0.06%)
At close: 3:29PM IST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close2,629.65
Bid0.00 x
Ask0.00 x
Day's Range2,620.00 - 2,647.70
52 Week Range2,555.20 - 3,689.85
Avg. Volume402,204
Market Cap435.83B
PE Ratio (TTM)45.85
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters6 days ago

    Indian drugmakers face squeeze in U.S. healthcare market

    India's small and medium-sized generic drugmakers say the threat of tougher rules and higher barriers for outsiders in the U.S. healthcare market will force many to find a niche or focus their expansion efforts on other countries. Cut-price generics sold by India's small- and medium-sized drugmakers have been critical in bringing down prices there. A more protectionist stance by President Donald Trump, with the prospect of import tariffs and the U.S. boosting local drug manufacturing, mean the operating environment for smaller generic players will get worse, executives at Indian companies said.

  • PR Newswire7 days ago

    CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories

    MONMOUTH JUNCTION, N.J., March 16, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), manufacturer of the CytoSorb® extracorporeal blood purification therapy that reduces excessive levels of inflammatory mediators in critically-ill and cardiac surgery patients, announced today that they have entered into a partnership with Dr. Reddy's Laboratories Ltd for the South African market. Under the terms of the agreement, Dr. Reddy's has the exclusive rights to distribute CytoSorb for intensive care, cardiac surgery, and other hospital applications in South Africa.

  • PR Newswirelast month

    Dr. Reddy's Expands Commercial Operations in Europe

    BASEL, Switzerland, February 8, 2017 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd  announced today the expansion of its commercial operations in Europe with the introduction of its portfolio of generics ...